arginine vasopressin has been researched along with natriuretic peptide, c-type in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Espiner, EA; Hunt, PJ; Nicholls, MG; Richards, AM; Yandle, TG | 1 |
| Hama, N; Itoh, H; Komatsu, Y; Mori, K; Nakao, K; Shirakami, G; Suga, S | 1 |
| Levin, ER; Rubin, SA | 1 |
| Fukui, T; Horio, T; Ikeda, M; Kohno, M; Kurihara, N; Murakawa, K; Takeda, T; Yasunari, K; Yokokawa, K | 1 |
| Donald, RA; Ellis, MJ; Evans, MJ; Livesey, JH; Mulligan, RS | 1 |
| Hanehira, T; Kohno, M; Yoshikawa, J | 1 |
| Eto, S; Inenaga, K; Kangawa, K; Morimoto, I; Yamamoto, S; Yamashita, H; Yanagihara, N | 1 |
| Nanbu, A; Nishimura, M; Ohtsuka, K; Sakamoto, M; Takahashi, H; Yoshimura, M | 1 |
| Abbey, SE; Potter, LR | 1 |
| Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS | 1 |
1 trial(s) available for arginine vasopressin and natriuretic peptide, c-type
| Article | Year |
|---|---|
Bioactivity and metabolism of C-type natriuretic peptide in normal man.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Creatinine; Cyclic GMP; Epinephrine; Hormones; Humans; Hydrocortisone; Infusions, Intravenous; Male; Metabolic Clearance Rate; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Norepinephrine; Potassium; Reference Values; Single-Blind Method; Sodium; Time Factors | 1994 |
9 other study(ies) available for arginine vasopressin and natriuretic peptide, c-type
| Article | Year |
|---|---|
Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Injections, Intraventricular; Male; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Rats; Rats, Wistar; Stimulation, Chemical | 1993 |
Clinical review 53: The endocrinology of vasoactive peptides: synthesis to function.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Vessels; Endocrine Glands; Endothelins; Humans; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Peptide Biosynthesis; Peptides | 1994 |
Natriuretic peptides inhibit mesangial cell production of endothelin induced by arginine vasopressin.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclic GMP; Endothelins; Glomerular Mesangium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 1993 |
Atrial natriuretic peptide and C-type natriuretic peptide do not acutely inhibit the release of adrenocorticotropin from equine pituitary cells in vitro.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Corticotropin-Releasing Hormone; Female; Horses; Hydrocortisone; Kinetics; Male; Natriuretic Peptide, C-Type; Pituitary Gland, Anterior; Proteins | 1997 |
Endothelin production in cultured vascular smooth muscle cells--modulation by the atrial, brain, and C-type natriuretic peptide system.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Brain-Derived Neurotrophic Factor; Cells, Cultured; Endothelins; Enzyme Inhibitors; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Protein Kinase C; Proteins; Rats; Rats, Sprague-Dawley | 1997 |
C-type natriuretic peptide suppresses arginine-vasopressin secretion from dissociated magnocellular neurons in newborn rat supraoptic nucleus.
Topics: Animals; Animals, Newborn; Arginine Vasopressin; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Male; Natriuretic Peptide, C-Type; Neurons; Proteins; Rats; Rats, Wistar; Supraoptic Nucleus | 1997 |
Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain; Desoxycorticosterone; Hypertension; Infusions, Parenteral; Injections, Intravenous; Injections, Intraventricular; Male; Natriuretic Peptide, C-Type; Rats; Rats, Wistar; Sodium Chloride; Tetrazoles | 1998 |
Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations.
Topics: Animals; Aorta; Arginine Vasopressin; Atrial Natriuretic Factor; Calcium; Cell Membrane; Cells, Cultured; Cyclic AMP; Guanylate Cyclase; Kinetics; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Rats; Receptors, Atrial Natriuretic Factor; Tetradecanoylphorbol Acetate; Vasopressins | 2002 |
Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
Topics: Angiotensin II; Aquaporin 2; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Case-Control Studies; Exercise; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Osmolar Concentration; Radioimmunoassay | 2004 |